ES2609459T8 - Compuestos heterocíclicos condensados y su uso - Google Patents

Compuestos heterocíclicos condensados y su uso Download PDF

Info

Publication number
ES2609459T8
ES2609459T8 ES13759274.7T ES13759274T ES2609459T8 ES 2609459 T8 ES2609459 T8 ES 2609459T8 ES 13759274 T ES13759274 T ES 13759274T ES 2609459 T8 ES2609459 T8 ES 2609459T8
Authority
ES
Spain
Prior art keywords
heterocyclic compounds
condensed heterocyclic
condensed
compounds
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13759274.7T
Other languages
English (en)
Other versions
ES2609459T3 (es
Inventor
Keith Jones
Matthew David CHEESEMAN
Spyridon Linardopoulos
Amir FAISAL
Olivier Remi BARBEAU
Andrew KALUSA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research Royal Cancer Hospital
Original Assignee
Institute of Cancer Research Royal Cancer Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research Royal Cancer Hospital filed Critical Institute of Cancer Research Royal Cancer Hospital
Application granted granted Critical
Publication of ES2609459T3 publication Critical patent/ES2609459T3/es
Publication of ES2609459T8 publication Critical patent/ES2609459T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES13759274.7T 2012-08-23 2013-08-22 Compuestos heterocíclicos condensados y su uso Active ES2609459T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261692321P 2012-08-23 2012-08-23
US201261692321P 2012-08-23
PCT/GB2013/052213 WO2014030001A1 (en) 2012-08-23 2013-08-22 Fused heterocyclic compounds and their use

Publications (2)

Publication Number Publication Date
ES2609459T3 ES2609459T3 (es) 2017-04-20
ES2609459T8 true ES2609459T8 (es) 2017-05-30

Family

ID=49118569

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13759274.7T Active ES2609459T3 (es) 2012-08-23 2013-08-22 Compuestos heterocíclicos condensados y su uso

Country Status (4)

Country Link
US (1) US9550764B2 (es)
EP (1) EP2888254B1 (es)
ES (1) ES2609459T3 (es)
WO (1) WO2014030001A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9694033B2 (en) 2014-01-24 2017-07-04 The Cleveland Clinic Foundation IL-9 secreting CD8+ Tc9 cells and methods of treating cancer
CN105541793B (zh) * 2016-01-04 2018-08-10 河北国龙制药有限公司 曲格列汀的合成方法
WO2020181232A1 (en) 2019-03-06 2020-09-10 C4 Therapeutics, Inc. Heterocyclic compounds for medical treatment
US20210147441A1 (en) * 2019-09-26 2021-05-20 Agency For Science, Technology And Research (A*Star) Therapeutic compounds and methods of use thereof
WO2026071094A1 (en) * 2024-09-30 2026-04-02 Alivexis, Inc. Kit inhibitors, compounds, pharmaceutical compositions, and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0934937T3 (da) * 1990-11-30 2002-04-02 Otsuka Pharma Co Ltd Azolderivater som superoxidradikalinhibitor
EP3037419B1 (en) 2007-09-06 2019-09-04 Boston Biomedical, Inc. Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases

Also Published As

Publication number Publication date
EP2888254A1 (en) 2015-07-01
EP2888254B1 (en) 2016-10-05
US9550764B2 (en) 2017-01-24
US20150232462A1 (en) 2015-08-20
ES2609459T3 (es) 2017-04-20
WO2014030001A1 (en) 2014-02-27

Similar Documents

Publication Publication Date Title
IL269045A (en) Aptamers and uses thereof
CR20150380A (es) Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico
CO6930362A2 (es) Compuesto heterocíclico y su uso
HRP20181392T1 (hr) Heterociklični spojevi i njihova uporaba
PT3052485T (pt) Compostos heterocíclicos e suas utilizações
HRP20181628T1 (hr) Spojevi i postupci za njihovu upotrebu
EP2661839A4 (en) SAFE PORTABLE ELEMENT
EP2872093A4 (en) DIAPER PANTS
EP4144845C0 (en) ANTISENSE COMPOUNDS AND THEIR USES
CO6801774A2 (es) Compuestos de benzotiazol y su uso farmacéutico
EP2872089A4 (en) CONTAINMENT TROUSERS
DK2864426T3 (da) Justerbare materialer
BR112014030917A2 (pt) artigo absorvente
PT2730564T (pt) Aminas heterocíclicas e suas utilizações
PL2664816T4 (pl) Rozpora teleskopowa
BR112015001628A2 (pt) polipeptídeos de fator x modificados e uso dos mesmos
CO7000747A2 (es) Anticuerpos anti-lrp5 y métodos de uso
IL238227A0 (en) Anti-c16orf54 antibodies and methods of use thereof
CO6990717A2 (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
EP2832855A4 (en) NOVEL ANTI-SIGLEC-15 ANTIBODY
BR112014026835A2 (pt) artigo absorvente
BR112014009006A2 (pt) compostos heterocíclicos e métodos de uso dos mesmos
PL3030519T3 (pl) Trójpierścieniowe związki benzoksaborolu i ich zastosowania
BR112015014598A2 (pt) artigo absorvente
SMT201600211B (it) Composti eterociclici e loro usi